SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome

Myelodysplasia (MDS) /myeloproliferative neoplasm (MPN) overlap syndrome has been described since the 2001 WHO classification as disorders that have both proliferative and dysplastic changes simultaneously. Specific disorders include chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic le...

Descripción completa

Detalles Bibliográficos
Autores principales: Linder, Katherine, Iragavarapu, Chaitanya, Liu, Delong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718013/
https://www.ncbi.nlm.nih.gov/pubmed/29225884
http://dx.doi.org/10.1186/s40364-017-0113-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718013/
https://www.ncbi.nlm.nih.gov/pubmed/29225884
http://dx.doi.org/10.1186/s40364-017-0113-8

Ejemplares similares